Superior Group of Companies Reports Second Quarter 2026 Results

Superior Group of Companies (NASDAQ: SGC) reported Q2 2026 net sales of $147.8 million, up from $144.0 million a year earlier. Net income was $1.2 million, including a $2.6 million trade name impairment charge in Healthcare Apparel. Adjusted EBITDA rose to $7.7 million. The company confirmed 2026 outlook and declared a $0.14 per share quarterly dividend.

Original reporting
Published Aug 4, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SGC
Bullish
medium confidence
Mentioned
$SGC
Relevance
8/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$SGCBullishMed
01

Why it matters

The release combines Q2 operating performance, a non-cash impairment disclosure, and a quantified full-year net sales and adjusted EPS outlook, plus a new quarterly dividend declaration.

02

Market read

Traders can update models using the provided Q2 metrics and the full-year net sales and adjusted EPS ranges, and price in the dividend and seasonality framing.

03

What to watch

Dividend timing (payable Aug. 28, record Aug. 14) and the back-half seasonality referenced in guidance could matter for near-term positioning and options pricing.

Relevance 8/10Novelty 8/10Timing: pre-market today, Q2 results and full-year guidance released

Background

Superior Group of Companies (SGC) is a diversified provider across Healthcare Apparel, Branded Products, and Contact Centers.

Company-level read

Ticker impact

$SGCBullishMedium confidence
Context

Superior Group of Companies reported Q2 2026 net sales of $147.8M, adjusted EBITDA of $7.7M, and confirmed full-year outlook.

Expected impact

Likely supportive for the stock versus peers if the market focuses on guidance confirmation and adjusted EPS strength, with volatility around the non-cash impairment.

Evidence & confidence

The article provides concrete quarterly performance metrics, a specific non-cash impairment detail, and a quantified full-year sales and adjusted EPS range, which are direct inputs to valuation and positioning.

Market effects

Adds datapoint on demand resilience in apparel/contact-center end markets, but limited sector-wide read-through.

No specific regional catalyst beyond company-level results.

Minimal global spillover; guidance is company-specific.

Counterpoint

The headline net income is pressured by a $2.6M trade name impairment, so investors may discount adjusted strength if they expect further non-cash charges or margin pressure.

Key entities

  • Superior Group of Companies, Inc.

    Reported Q2 2026 results, disclosed a trade name impairment in Healthcare Apparel, confirmed full-year 2026 outlook, and declared a $0.14/share quarterly dividend.

  • Michael Benstock

    CEO quoted on adjusted EPS strength, soft market navigation, and guidance reflecting stronger back-half results.

Related articles

$SGCMedAI 8/10

Superior Group (SGC) Q2 2026 Earnings Call Transcript

Superior Group of Companies (SGC) reported Q2 2026 revenue of $147.8 million, up 3% year over year, with Branded Products revenue rising to $98.4 million. Adjusted diluted EPS was $0.21 versus $0.10, and adjusted EBITDA rose 27% to $7.7 million. The company guided full-year sales to $572-$585 million and adjusted EPS to $0.54-$0.66.

$SGCMed

Superior Group of Companies Q2 Earnings Call Highlights

Superior Group of Companies (NASDAQ:SGC) reported Q2 results on an earnings call. Healthcare Apparel revenue fell 4% to $27M; gross margin was 32.9% after a $2.6M non-cash inventory write-down and $2.6M impairment charge. Contact Centers revenue fell 4% to $23M but improved sequentially. Net income was $1.2M; adjusted EPS $0.21. SGC reaffirmed 2026 net sales $572M-$585M and adjusted EPS $0.54-$0.66.

$SGCMed

SUPERIOR GROUP OF COMPANIES, INC. (SGC): Results of Operations and Financial Condition

SUPERIOR GROUP OF COMPANIES, INC. (SGC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE SUPERIOR GROUP OF COMPANIES REPORTS SECOND QUARTER 2026 RESULTS • Total net sales of $147.8 million, up from $144.0 million in prior year second quarter • Net income of $1.2 million, including a non-cash tradename impairment charge, $2 million a

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.

$AVGOMedAI 9/10

Broadcom’s AI Forecast Suggests Hyperscalers Want More Than Just Nvidia GPUs

Broadcom (AVGO) raised its AI chip revenue forecast to $115B for FY2027, up from $100B, and expects $230B in FY2028. This reflects Big Tech's demand for custom chips and networking components, reducing reliance on Nvidia (NVDA). KeyBanc reiterated an Overweight rating and $575 price target for AVGO. AVGO's Q3 revenue rose 86% YoY to $29.6B, but Q4 guidance was slightly below expectations. Hedge funds hold positions in both AVGO and NVDA, with Fisher Asset Management among the top holders.